Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The D84G mutation in STIM1 causes nuclear envelope dysfunction and myopathy in mice
Victoria Bryson, Chaojian Wang, Zirui Zhou, Kavisha Singh, Noah Volin, Eda Yildirim, Paul Rosenberg
Victoria Bryson, Chaojian Wang, Zirui Zhou, Kavisha Singh, Noah Volin, Eda Yildirim, Paul Rosenberg
View: Text | PDF
Research Article Cell biology Muscle biology

The D84G mutation in STIM1 causes nuclear envelope dysfunction and myopathy in mice

  • Text
  • PDF
Abstract

Stromal interaction molecule 1 (STIM1) is a Ca2+ sensor located in the sarcoplasmic reticulum (SR) of skeletal muscle, where it is best known for its role in store-operated Ca2+ entry (SOCE). Genetic syndromes resulting from STIM1 mutations are recognized as a cause of muscle weakness and atrophy. Here, we focused on a gain-of-function mutation that occurs in humans and mice (STIM1+/D84G mice), in which muscles exhibited constitutive SOCE. Unexpectedly, this constitutive SOCE did not affect global Ca2+ transients, SR Ca2+ content, or excitation-contraction coupling (ECC) and was therefore unlikely to underlie the reduced muscle mass and weakness observed in these mice. Instead, we demonstrate that the presence of D84G STIM1 in the nuclear envelope of STIM1+/D84G muscle disrupted nuclear-cytosolic coupling, causing severe derangement in nuclear architecture, DNA damage, and altered lamina A–associated gene expression. Functionally, we found that D84G STIM1 reduced the transfer of Ca2+ from the cytosol to the nucleus in myoblasts, resulting in a reduction of [Ca2+]N. Taken together, we propose a novel role for STIM1 in the nuclear envelope that links Ca2+ signaling to nuclear stability in skeletal muscle.

Authors

Victoria Bryson, Chaojian Wang, Zirui Zhou, Kavisha Singh, Noah Volin, Eda Yildirim, Paul Rosenberg

×

Figure 5

Nuclear abnormalities in muscles of STIM1+/D84G mice.

Options: View larger image (or click on image) Download as PowerPoint
Nuclear abnormalities in muscles of STIM1+/D84G mice.
(A) Immunostaining...
(A) Immunostaining for STIM1 (green) and nuclei (DAPI, blue) in WT mice (male and female) (n >6). Scale bar: 10 μm. (B) Electron micrograph showing expression of STIM LacZ (white arrows) in the nuclear envelope of STIM1gt/+ mice as detected by X-gal staining (n >4). Scale bar: 500 nm. (C) Western blots showing STIM1 expression in the nuclear and cytosolic fractions. (D and E) STIM1 expression in D84G fibers (n >6). Scale bar: 10 μm. (F–H) Nuclear abnormalities in D84G mice as demonstrated by DAPI staining (blue) (n = 7 mice per genotype). (F and G) Nuclei along the length of the fiber in WT (F) and STIM1+/D84G (G) mice. Scale bar: 50 μm. (H) Quantification of abnormal nuclei (large, clumped, lobular or fragmented) (percentage) in WT and STIM1+/D84G mice. Values are the mean ± SD. n = 7 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, by 2-tailed Student’s t test (NS, P > 0.05). Data are shown as the average number of abnormal nuclei in all fibers (n = 48 fibers per genotype). (I–P) Transmission electron micrographs of nuclei in TA muscles of WT (I) and STIM1+/D84G (J–P) mice (n >3). Scale bar: 2 μm. (J) D84G nucleus with fragmented micronuclei (red arrow). (K and N) D84G nuclei with dilated PNS (green arrows). (K) D84G nuclei with condensed chromatin (blue arrow). (L) Vacuolated nucleus in D84G mice (purple arrow). (M) Pale, fading nucleus suggesting karyolysis (black arrow). (O and P) Vacuolated nuclear membrane (yellow arrows).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts